期刊文献+

血浆循环DNA浓度在原发性干燥综合征和系统性红斑狼疮诊治中的意义 被引量:2

Plasma circulating DNA levels in patients with primary Sj(o|¨)gren's syndrome and systemic lupus erythematosus
下载PDF
导出
摘要 目的比较原发干燥综合征(pSS)、系统性红斑狼疮(SLE)患者外周血浆中循环DNA(cDNA)浓度的差异性,探讨cDNA浓度在pSS、SLE诊治中的意义。方法选用人类基因组管家基因甘油醛-3-磷酸脱氢酶(GAPDH)设计引物,测定pSS、SLE及健康对照组中血浆cDNA浓度,同时测定血沉(ESR)、C-反应蛋白(CRP)、免疫球蛋白(IgA、IgG、IgM)并评定不同疾病的活动指数和损害指数,分析血浆cDNA浓度与疾病活动性、相关参数的关系。结果 pSS组cDNA浓度[(368.24±196.68)ng/ml]明显高于SLE组[(244.51±164.10)ng/ml]及健康对照组[(24.56±16.76)ng/ml],差异均有统计学意义(均P<0.05);pSS组中的cDNA浓度值与干燥综合征活动指数(SSDAI)呈正相关(P<0.05),与干燥综合征损害指数(SSDDI)无相关性(P>0.05);SLE组中cDNA浓度值与SLE活动指数(SLEDAI)无相关性(P>0.05)。结论 cDNA浓度可作为pSS与SLE鉴别指标之一,pSS患者cDNA浓度与SSDAI呈正相关,可作为pSS疾病活动性观察指标之一。 Objective To investigate the plasma circulating DNA (cDNA)levels in patients with primary Sjogren's syn-drome(pSS) and systemic lupus erythematosus(SLE), and its clinical significance. Methods The primer was designed by human genome housekeeper gene GAPDH. Levels of cDNA, erythrocyte sedimentation rate (ESR), C- reaction protein (CRP) and im-munoglobulin (IgA, IgG and IgM) in each group were detected. Meanwhile, the activity index and damage index of different dis-eases were assessed, and the relations between cDNA and disease activity were analyzed. Results The levels of plasma cDNA in pSS group (368.24±196.68ng/ml) were apparently higher than those in SLE group (244.51±164.10ng/ml) and normal control group (24.56±16.76ng/ml),and the differences were significant statistical y (both P〈0.05).The levels of cDNA in each disease group were significantly higher than those in normal control group (both P〈0.05).In pSS group:cDNA level was positively corre-lation with Sjogren's syndrome disease activity index (SSDAI)(P〈0.05).But there was no correlation between cDNA concentration and Sjogren's syndrome disease damage index (SSDDI)(P〉0.05). In SLE group:cDNA level did not correlate with SLE disease activity index(SLEDAI)(P〉0.05). Conclusion The cDNA level may be a valuable indicator for distinguishing pSS from SLE.And it can be taken as one of the disease activity indices of pSS.
出处 《浙江医学》 CAS 2013年第18期1637-1639,1691,共4页 Zhejiang Medical Journal
基金 嘉兴市科技计划项目(2013AY21043-11)
关键词 血浆循环DNA 原发性干燥综合征 系统性红斑狼疮 干燥综合征活动指数 干燥综合征损害指数 系统性红斑狼疮活动指数 Plasma circulating DNA Primary Sjogren's Syndrome Systemic lupus erythematosus Sjogren's syn-drome disease activity index Sjogren's syndrome disease damage index SLE disease activity index
  • 相关文献

参考文献10

  • 1Vitali C, Bombardieri S, Jonsson R, et al. Classification criteria for Sjogren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group[J].Ann Rheum Dis,2002,61(6): 554-558.
  • 2Tan E M, Cohen A S, Fries J F, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus[J]. Arthritis Rheum,1982, 25(11): 1271-1277.
  • 3Arnalich F,Codoceo R,Lopez-Collazo E,et aI.Circulating cell-free mitochondrial DNA: a better early prognostic marker in patients with out-of-hospital cardiac arrest[J]. Resuscitation, 2012, 83(7): 162-163.
  • 4Suzuki N,Kamataki A,Yamaki J, et aI.Characterization of circulating DNA in healthy human plasma[J]. Clin Chim Acta, 2008, 387(1-2): 55- 58.
  • 5Arnalich F, Codoceo R, Lopez-Colrazo E,et al. Circulating cell-free mitochondrial DNA: a better early prognostic marker in patients with out-of-hospital cardiac arrest[J]. Resuscitation, 2012, 83(7): 162-163.
  • 6Breitbach S, Tug S, Simon P. Circulating cell-free DNA: an up- coming molecular marker in exercise physiology[J]. Sports Med, 2012,42(7): 565-586.
  • 7Bartoloni E, Ludovini V, Alunnol A,et al.lncreased levels of circu- lating DNA in patients with systemic autoimmune diseases: A possible marker of disease activity in Sjogren's syndrome[J]. Lu- pus,2011,20(9): 928-935.
  • 8Cherepanova A V, Bushuev A V, Duzhak T G,et aI.Ku protein as the main cellular target of cell-surface-bound circulating DNA[J]. Expert Opin Biol Ther,2012,12 (1): 35-41.
  • 9Delgado P O, AIves B C, Gehrke Fde S, et al.Characterization of cell-free circulating DNA in plasma in patients with prostate can- cer[J]. Tumour Biol, 2013,34(2):983-986.
  • 10Cepika A M, Soldo Juresa D, Morovic Vergles J,et al. Decrease in circulating DNA, IL-10 and BAFF levels in newly-diagnosedSLE patients after corticosteroid and chloroquine treatment[J]. Cell Immunol, 2012,276(1-2):196-203.

同被引文献22

  • 1苏加利,杜万红.原发性干燥综合征误行脾切除1例[J].华南国防医学杂志,2000,14(3):42-43. 被引量:1
  • 2Dmit ry Zayt sev, Sergei Grigoriev, Peter Panfilov. Deformation behavior of root dentin under Sjoegren's syndrome [J ]. Materials Letters, 2011,65(15-16) :2435-2438.
  • 3Espinosa A, Hennig J, Ambrosi A, et al . Anti Ro52 autoanti- bodies from patients with SjOgren's syndrome inhibit the Ro52 E3 ligase activity by blocking the E3/E2 interface[J]. J Biol Chem, 2011,286 (42) : 36478-36491.
  • 4Tzioufas AG, Vlachoyiannopoulos PG. Sj6gren's syndrome: An update on clinical, basic and diagnostic therapeutic aspects [J]. J Autoimmun, 2012, 39(1-2) :1 -3.
  • 5Szodoray P, Alex P, Brun J G, et al . Circulating cytokines in primary Sj6gren's syndrome determined by a multiplex cy- tokine array system[J]. Stand J Immunol, 2004, 59(6): 592-599.
  • 6Iannuccelli C, Spinelli FR, Guzzo MR, et al. Fatigue and widespread pain in systemic lupus erythematosus and Sj6gren 's syndrome: symptoms of inflammatory disease or associated fibromyalgia[J]? Clin Exp Rheumatol, 2012,30(74) :45- 50.
  • 7Vitali C, Bombardieri S, Jonsson R, et al. For european Study group on classification criteria for Sjogren's Syndrome. Classification criteria for Sj(~gren's syndrome:a revised version of the european criteria proposed by the American - European Consensus Group. Ann Rheum Dis, 2002, 61:554-558.
  • 8Vitali C, Palombi G, Baldini C, et al. SjOgren's Syndrome Disease Damage Index and disease activity index:scoring systems for the assessment of disease damage and disease activity in Sj(')gren's syndrome, derived from an analysis of a cohort of Italian patients. Arthritis Rheum, 2007, 56:2223-2231.
  • 9Coudray-Meunier C, Fraisse A, Martin-Latil S, et al. A novel high-throughout method for molecular detection of human pathogenic viruses using a nanofluidic real-time PCR system. PLoS One, 2015, 11(1):e0147832.
  • 10E Bartoloni, V Ludovini, A Alunno, et al. Increased levels of circulating DNA in patients with systemic autoimmune diseases:A possible marker of disease activity in Sj0gren's syndrome. Lupus, 2011, 20(9):928-935.

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部